NYSE:ABBV - New York Stock Exchange, Inc. - US00287Y1091 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 79% to ABBV. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-02-03 | Guggenheim | Maintains | Buy -> Buy |
2025-02-03 | BMO Capital | Maintains | Outperform -> Outperform |
2025-02-03 | UBS | Maintains | Neutral -> Neutral |
2025-02-03 | Wells Fargo | Maintains | Overweight -> Overweight |
2025-02-03 | Raymond James | Reiterate | Outperform -> Outperform |
2025-02-03 | Truist Securities | Maintains | Buy -> Buy |
2025-02-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
2025-02-03 | Citigroup | Maintains | Buy -> Buy |
2025-01-28 | Citigroup | Maintains | Buy -> Buy |
2025-01-08 | Truist Securities | Maintains | Buy -> Buy |
2024-12-17 | Piper Sandler | Maintains | Overweight -> Overweight |
2024-12-10 | B of A Securities | Reiterate | Neutral |
2024-11-22 | Leerink Partners | Upgrade | Market Perform -> Outperform |
2024-11-15 | Wolfe Research | Initiate | Outperform |
2024-11-13 | JP Morgan | Maintains | Overweight -> Overweight |
2024-11-12 | BMO Capital | Maintains | Outperform -> Outperform |
2024-11-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
2024-11-12 | Citigroup | Maintains | Buy -> Buy |
2024-11-06 | Guggenheim | Maintains | Buy -> Buy |
2024-11-04 | Argus Research | Upgrade | Hold -> Buy |
2024-10-31 | UBS | Maintains | Neutral -> Neutral |
2024-10-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
2024-10-31 | Citigroup | Maintains | Buy -> Buy |
2024-10-25 | Citigroup | Maintains | Buy -> Buy |
2024-10-18 | B of A Securities | Maintains | Neutral -> Neutral |
2024-10-17 | Bernstein | Initiate | Market Perform |
2024-10-17 | BMO Capital | Maintains | Outperform -> Outperform |
2024-10-10 | Truist Securities | Maintains | Buy -> Buy |
2024-10-09 | UBS | Maintains | Neutral -> Neutral |
2024-10-07 | TD Cowen | Maintains | Buy -> Buy |